awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38977288-3C7210F6-2427-479D-84D0-320CD33D8DDD
Q38977288-3C7210F6-2427-479D-84D0-320CD33D8DDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38977288-3C7210F6-2427-479D-84D0-320CD33D8DDD
Androgen receptor variation affects prostate cancer progression and drug resistance.
P2860
Q38977288-3C7210F6-2427-479D-84D0-320CD33D8DDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38977288-3C7210F6-2427-479D-84D0-320CD33D8DDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
16a0c756bda712833f4cfcbaff43e3d9e672f751
P2860
Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling.